3 days left
Architecture & engineering · South West Upcoming
Pathology Managed Service – Preliminary Market Engagement
Gloucestershire Hospitals NHS Foundation Trust · Expected to open February 2027
What this tender is
Gloucestershire Hospitals NHS Foundation Trust is seeking suppliers for “Pathology Managed Service – Preliminary Market Engagement”. It is classed as architecture & engineering services, with delivery in South West.
In the buyer's own words: Gloucestershire Hospitals NHS Foundation Trust (“the Authority”) is undertaking preliminary market engagement ahead of a competitive procurement for a Pathology Managed Service. The intended contract will provide, as a managed service, the laboratory equipment (analytical platforms, automation, point-of-care devices and associated instrumentation), reagents, consumables, maintenance, software/middleware, training and lifecycle replacement required to deliver the Authority’s pathology service. The service is expected to be structured in two phases: Phase 1 covering the Authority’s existing…
The procedure and any lots are set out in full on the official notice.
The estimated value is £150m, as stated by the buyer; the final value can differ.
Ktenders places each notice in a trade from the classification code the buyer chose and in a region from the delivery location it gives, so if the scope looks different from the trade shown here, the official notice is the one to trust.
Who it suits
This tender is most relevant to architecture & engineering suppliers able to deliver in South West.
At this size buyers usually expect evidence of similar work, appropriate insurance and stable finances, so smaller firms often bid as part of a consortium or as a subcontractor.
Public buyers in the UK must treat suppliers equally and explain how bids will be scored, so the selection and award criteria in the tender documents are the best guide to whether this opportunity is worth your time.
Before deciding to bid, read the full notice and any attached documents: they set out the exact requirements, selection criteria and how bids will be scored.
Key dates
The notice was published on 16 November 2026.
This is a pipeline notice: the buyer intends to run a procurement and expects it to open around February 2027. No bids can be submitted yet.
Pipeline notices give suppliers time to prepare. Many invite early market engagement — a questionnaire, a supplier day or a request for information — and taking part helps the buyer shape a tender that suits firms like yours. When the buyer publishes the full tender notice, it will appear on Ktenders with its closing date.
Dates in pipeline notices are estimates and often move, so register on the buyer's portal and check the official notice for updates rather than relying on the expected month alone.
Original notice text
Gloucestershire Hospitals NHS Foundation Trust (“the Authority”) is undertaking preliminary market engagement ahead of a competitive procurement for a Pathology Managed Service. The intended contract will provide, as a managed service, the laboratory equipment (analytical platforms, automation, point-of-care devices and associated instrumentation), reagents, consumables, maintenance, software/middleware, training and lifecycle replacement required to deliver the Authority’s pathology service.
The service is expected to be structured in two phases: Phase 1 covering the Authority’s existing laboratories at Gloucestershire Royal Hospital and Cheltenham General Hospital, and Phase 2 following consolidation into a new-build pathology hub. The Authority’s working direction is a new-build hub with the location not yet determined; two options remain under consideration, each with implications for the service model that suppliers should allow for:
A hub on the Gloucester (hospital) site would require continued urgent haematology and clinical chemistry provision at Cheltenham General.
An off-site hub would require acute (hot lab) provision and resilience at both Gloucestershire Royal and Cheltenham General. Transfusion provision should not be assumed at all three locations (remote issue, transport, storage, space and staffing remain dependencies); for microbiology, an off-site hub may require on-site blood-culture loading at the acute sites and further review of patient-facing sample collection and cryo/storage services. For cellular pathology, reliable frozen-section transport between sites would be essential.
The disciplines in scope are Blood Sciences (clinical biochemistry, haematology, coagulation, immunology, transfusion-related equipment where included), Infection Sciences (microbiology, virology/molecular) and Cellular Pathology, together with enabling works to prepare laboratory space for installation. The Authority anticipates a lead provider for Blood Sciences with further lots or sub-lots for the other disciplines; the lot structure is a matter on which market feedback is sought.
The Authority is seeking supplier feedback on the draft service specification, draft key performance indicators, the proposed lot structure and phasing, the commercial and pricing model, the evaluation approach and the proposed timetable, in order to finalise its procurement strategy and tender documents. Participation is open to all interested suppliers including SMEs, specialist providers and potential sub-contractors or consortium members.
More architecture & engineering tenders
3 days left
3 days left
3 days left
3 days left
3 days left
More tenders in South West
3 days left
5 days left
5 days left
5 days left
5 days left
5 days left
Closing soon
Closes today at 12:00
Closes today at 17:00
Closes tomorrow at 12:00
Closes tomorrow at 16:00
Closes tomorrow at 23:59
2 days left